ArticleScientific reports2019

Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells.

Diana Cervantes-Madrid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.